{"companyId":285625,"requestedLanguage":"en","resolvedLanguage":"en","availableLanguages":["en","ja"],"companyName":"Xenon Pharmaceuticals Inc.","headOfficeLocation":"200-3650 Gilmore Way Burnaby, BC V5G 4W8 Canada","presidentName":"Ian Mortimer","companySummary":null,"stockCode":"XENE","currency":"USD","capital":null,"sales":null,"employees":370,"employeesConsolidated":null,"humanCheck":false,"domains":["xenon-pharma.com"],"businessContents":["Clinical-stage neuroscience biopharmaceutical company","Ion channel-targeted drug development for epilepsy and neurological disorders"],"relations":[],"dataSources":[{"detailNumber":1,"url":"https://xenon-pharma.com/","scoreAbout":300,"scoreBusiness":200,"scoreGroup":0,"scoreCustomer":0}]}